- support
- info@evidentic.com
- +49 (0) 30 959 99 8831
Therapeutic Loncastuximab tesirine ADC from the original Zynlonta® commercial drug.
Showing the single result
ProductBatch | Antigen | Molecular Class | Drug Brand | Product Concentration | CoA | Quantity per vial | Storage Temperature | Expiry Date | Price from | |
|---|---|---|---|---|---|---|---|---|---|---|
CD19 |
Antibody-drug conjugate (ADC) |
Zynlonta® |
5 mg/mL |
– |
0,2 mg |
tba |
tba |
2.967,00 € |
Evidentic GmbH
Martin-Buber-Str. 10
14163 Berlin
